Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

IVA Relative to the S&P 500

IVA Relative to the Sector

Seasonal Chart Analysis

Analysis of the Inventiva S.A. (NASD:IVA) seasonal charts above shows that a Buy Date of August 10 and a Sell Date of October 30 has resulted in a geometric average return of 23.38% above the benchmark rate of the S&P 500 Total Return Index over the past 4 years. This seasonal timeframe has shown positive results compared to the benchmark in 4 of those periods. This is an excellent rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 4 years by an average of 68.78% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 4 years of data is available for shares of IVA, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Fr d ric Cren on October 27, 2011 and is headquartered in Daix, France.

To download IVA seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: IVA